The historical rank and industry rank for Cannabis Global's EV-to-EBIT or its related term are showing as below:
CBGL's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.865 * Ranked among companies with meaningful EV-to-EBIT only.
Cannabis Global (OTCPK:CBGL) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Cannabis Global's Enterprise Value for the quarter that ended in May. 2022 was $10.05 Mil.
Cannabis Global's EBIT for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Global EV-to-EBIT Related Terms
Cannabis Global EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Cannabis Global's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cannabis Global EV-to-EBIT vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Cannabis Global's EV-to-EBIT falls into.
Cannabis Global's current Enterprise Value is $0.66 Mil.
Cannabis Global's EBIT for the trailing twelve months (TTM) ended in May. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.38 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cannabis Global (CBGL) has a EV-to-EBIT of 0.48 as of Jul. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cannabis Global and its competitors.
Is Cannabis Global's EV-to-EBIT too high?
Cannabis Global's current EV-to-EBIT is 0.48. The Drug Manufacturers industry median EV-to-EBIT is 15.87. Cannabis Global's value of 0.48 is 97% below this industry median.
How does Cannabis Global's EV-to-EBIT compare to MILC and BBBT?
Cannabis Global's EV-to-EBIT of 0.48 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.87. Cannabis Global's value of 0.48 is 97% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.87, based on 688 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cannabis Global's current EV-to-EBIT of 0.48 is 97% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Cannabis Global and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cannabis Global's current EV-to-EBIT is 0.48. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cannabis Global stock overvalued right now?
Cannabis Global (CBGL) has a current EV-to-EBIT of 0.48. The current EV-to-EBIT is 0.48 and 97% below the Drug Manufacturers industry median of 15.87. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Cannabis Global (CBGL), the current EV-to-EBIT is 0.48 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cannabis Global Inc manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CBGL has been successfully added to your 